Cargando…

Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells

To explore the molecular mechanisms of action underlying the antileukemia activities of darinaparsin, an organic arsenical approved for the treatment of peripheral T–cell lymphoma in Japan, cytotoxicity of darinaparsin was evaluated in leukemia cell lines NB4, U-937, MOLT-4 and HL-60. Darinaparsin w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Bo, Kikuchi, Hidetomo, Li, Jingmei, Kawabata, Atsushi, Yao, Kozo, Takagi, Norio, Okazaki, Mari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916914/ https://www.ncbi.nlm.nih.gov/pubmed/36768603 http://dx.doi.org/10.3390/ijms24032282

Ejemplares similares

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
por: Nielsen, Torsten H., et al.
Publicado: (2013)

Enhanced Cytotoxic Effects of Arenite in Combination with Active Bufadienolide Compounds against Human Glioblastoma Cell Line U-87
por: Yuan, Bo, et al.
Publicado: (2022)

Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines
por: Yuan, Bo, et al.
Publicado: (2021)

Corrigendum: Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines
por: Yuan, Bo, et al.
Publicado: (2021)

JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine via Modulating Cell Cycle Progression in Human Breast Cancer Cells
por: Yu, Bowen, et al.
Publicado: (2020)

Dimethylarsinothioyl Glutathione as a Metabolite in Human Multiple Myeloma Cell Lines upon Exposure to Darinaparsin
por: Yehiayan, Lucy, et al.
Publicado: (2014)

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
por: Kim, Won-Seog, et al.
Publicado: (2023)

Darinaparsin Is a Multivalent Chemotherapeutic Which Induces Incomplete Stress Response with Disruption of Microtubules and Shh Signaling
por: Mason, Twila A., et al.
Publicado: (2011)

Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma
por: Negoro, Eiju, et al.
Publicado: (2023)

Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells
por: Zhang, Yu, et al.
Publicado: (2021)

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
por: Ogura, Michinori, et al.
Publicado: (2020)

Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis
por: Alex, Ansu Abu, et al.
Publicado: (2018)

Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells
por: Zhao, Yuxue, et al.
Publicado: (2019)

Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells
por: Zhao, Yuxue, et al.
Publicado: (2020)

Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line
por: Wei, Xia, et al.
Publicado: (2019)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Organic Compounds of Arsenic
Publicado: (1909)

Arsenic in leukemia: A RSKy business
por: Dent, Paul
Publicado: (2013)

Curcumin Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in U266 Cells by Increasing Arsenic Uptake
por: Han, Dingding, et al.
Publicado: (2021)

Differential cytotoxic effects of arsenic on human and animal cells.
por: Lee, T C, et al.
Publicado: (1994)

Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
por: Yedjou, Clement, et al.
Publicado: (2009)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

Biosensors for Inorganic and Organic Arsenicals
por: Chen, Jian, et al.
Publicado: (2014)

Poisoning by Organic Compounds of Arsenic
Publicado: (1910)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
por: Yuan, Bo, et al.
Publicado: (2018)

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
por: Udensi, Udensi K, et al.
Publicado: (2011)

G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells
por: Fu, Wanbin, et al.
Publicado: (2022)

Organic Arsenicals in the Treatment of Simian Malaria
por: Gupta, B. M. Das, et al.
Publicado: (1944)

Neurological Complications of Organic Arsenical Injections
por: Shafar, J.
Publicado: (1943)

Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals
por: Fan, Xiao-Yang, et al.
Publicado: (2016)

UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control
por: Wang, Xiao-Bo, et al.
Publicado: (2022)

Expanding the Study of the Cytotoxicity of Incomptines A and B against Leukemia Cells
por: Calzada, Fernando, et al.
Publicado: (2022)

Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
por: Iriyama, Noriyoshi, et al.
Publicado: (2012)

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
por: Chau, David, et al.
Publicado: (2015)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Arsenic, Organic Foods, and Brown Rice Syrup
por: Jackson, Brian P., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f563295h4o544q8khu0e23l07e